EDP Sciences logo
Subscriber Authentication Point
Search
Menu
All issues Volume 20 (2025) Math. Model. Nat. Phenom., 20 (2025) 15 References
Issue
Math. Model. Nat. Phenom.
Volume 20, 2025
Special Issue to honour Vitaly's work
Article Number 15
Number of page(s) 17
DOI https://doi.org/10.1051/mmnp/2025012
Published online 14 May 2025
  1. L.S. Goodman et al., Goodman and Gilman's the Pharmacological Basis of Therapeutics, Vol. 1549. McGraw-Hill, New York (1996). [Google Scholar]
  2. J.W. Tyner, F. Haderk, A. Kumaraswamy, L.B. Baughn, B. Van Ness, S. Liu, H. Marathe, J.J. Alumkal, T.G. Bivona, K.S. Chan et al., Understanding drug sensitivity and tackling resistance in cancer. Cancer Res. 82 (2022) 1448-1460. [CrossRef] [PubMed] [Google Scholar]
  3. B. Ruffell and L.M. Coussens, Macrophages and therapeutic resistance in cancer. Cancer cell 27 (2015) 462-472. [CrossRef] [PubMed] [Google Scholar]
  4. J.B. Mitchem, D.J. Brennan, B.L. Knolhoff, B.A. Belt, Y. Zhu, D.E. Sanford, L. Belaygorod, D. Carpenter, L. Collins, D. Piwnica Worms et al., Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses. Cancer Res. 73 (2013) 1128-1141. [CrossRef] [PubMed] [Google Scholar]
  5. T. Shree, O.C. Olson, B.T. Elie, J.C. Kester, A.L. Garfall, K. Simpson, K.M. Bell McGuinn, E.C. Zabor, E. Brogi and J.A. Joyce, Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev. 25 (2011) 2465-2479. [CrossRef] [PubMed] [Google Scholar]
  6. O.C. Olson, H. Kim, D.F. Quail, E.A. Foley and J.A. Joyce, Tumor-associated macrophages suppress the cytotoxic activity of antimitotic agents. Cell Rep. 19 (2017) 101-113. [CrossRef] [Google Scholar]
  7. C.J. Halbrook, C. Pontious, I. Kovalenko, L. Lapienyte, S. Dreyer, H.-J. Lee, G. Thurston, Y. Zhang, J. Lazarus, P. Sajjakulnukit et al., Macrophage-released pyrimidines inhibit gemcitabine therapy in pancreatic cancer. Cell Metab. 29 (2019) 1390-1399. [CrossRef] [Google Scholar]
  8. Y. Yin, S. Yao, Y. Hu, Y. Feng, M. Li, Z. Bian, J. Zhang, Y. Qin, X. Qi, L. Zhou et al., The immune-microenvironment confers chemoresistance of colorectal cancer through macrophage-derived il6. Clin. Cancer Res. 23 (2017) 7375-7387. [CrossRef] [PubMed] [Google Scholar]
  9. X. Zhang, Y. Chen, L. Hao, A. Hou, X. Chen, Y. Li, R. Wang, P. Luo, Z. Ruan, J. Ou et al., Macrophages induce resistance to 5-fluorouracil chemotherapy in colorectal cancer through the release of putrescine. Cancer Lett. 381 (2016) 305-313. [CrossRef] [Google Scholar]
  10. M. Malier, K. Gharzeddine, M.-H. Laverriere, S. Marsili, F. Thomas, M. Court, T. Decaens, G. Roth and A. Millet, Hypoxia drives dihydropyrimidine dehydrogenase expression in macrophages and confers chemoresistance in colorectal cancer. Cancer Res. 81 (2021) 5963-5976. [CrossRef] [PubMed] [Google Scholar]
  11. Z. Cui, S. He, F. Wen, L. Lu, L. Xu, H. Wu and S. Wu, Dihydropyrimidine dehydrogenase (dpd) as a bridge between the immune microenvironment of colon cancers and 5-fu resistance. Front. Biosci Landmark 28 (2023) 80. [CrossRef] [PubMed] [Google Scholar]
  12. A. Ghaffarizadeh, R. Heiland, S.H. Friedman, S.M. Mumenthaler and P. Macklin, Physicell: an open source physics-based cell simulator for 3-d multicellular systems. PLoS Computat. Biol. 14 (2018) e1005991. [CrossRef] [Google Scholar]
  13. R. Heiland, D. Bergman, B. Lyons, J. Cass, H.L. Rocha, M. Ruscone, V. Noel and P. Macklin, Physicell studio: a graphical tool to make agent-based modeling more accessible. (2024) DOI: https://doi.org/10.46471/gigabyte.128. [Google Scholar]
  14. F. Di Mauro and G. Arbore, Spatial dissection of the immune landscape of solid tumors to advance precision medicine. Cancer Immunol. Res. 12 (2024) 800-813. [CrossRef] [PubMed] [Google Scholar]
  15. J.E. Bader, M.M. Wolf, G.L. Lupica-Tondo, M.Z. Madden, B.I. Reinfeld, E.N. Arner, E.S. Hathaway, K.K. Steiner, G.A. Needle, Z. Hatem et al., Obesity induces pd-1 on macrophages to suppress anti-tumour immunity. Nature 630 (2024) 968-975. [CrossRef] [PubMed] [Google Scholar]
  16. M. Bied, W.W. Ho, F. Ginhoux and C. Bkeriot, Roles of macrophages in tumor development: a spatiotemporal perspective. Cell. Mol. Immunol. 20 (2023) 983-992. [CrossRef] [Google Scholar]
  17. M.R. Owen and J.A. Sherratt, Pattern formation and spatiotemporal irregularity in a model for macrophage-tumour interactions. J. Theor. Biol. 189 (1997) 63-80. [CrossRef] [Google Scholar]
  18. S. Sakuramoto, M. Sasako, T. Yamaguchi, T. Kinoshita, M. Fujii, A. Nashimoto, H. Furukawa, T. Nakajima, Y. Ohashi, H. Imamura et al., Adjuvant chemotherapy for gastric cancer with s-1, an oral fluoropyrimidine. N. Engl. J. Med. 357 (2007) 1810-1820. [CrossRef] [PubMed] [Google Scholar]
  19. M.A. Cannarile, M. Weisser, W. Jacob, A.-M. Jegg, C.H. Ries and D. Ruttinger. Colony-stimulating factor 1 receptor (csf1r) inhibitors in cancer therapy. J. Immunother. Cancer 5 (2017) 53. [CrossRef] [Google Scholar]
  20. K. Gharzeddine, C. Gonzales Pietro, M. Malier, C. Hennot, R. Grespan, Y. Yamaryo Botte, C.Y. Botte, F. Thomas, M.-H. Laverriere, E. Girard et al. , Metabolic reprogramming of hypoxic tumour-associated macrophages through csf-1r targeting favours treatment efficiency in colorectal cancers. J. Immunother. Cancer 12 (2024) e009602. [CrossRef] [Google Scholar]
  21. H. Knutsdottir, E. Palsson and L. Edelstein-Keshet, Mathematical model of macrophage-facilitated breast cancer cells invasion. J. Theoret. Biol. 357 (201) 184-199. [Google Scholar]
  22. M. Chaplain and A. Matzavinos, Mathematical modelling of spatio-temporal phenomena in tumour Immunology, in Tutorials in Mathematical Biosciences III: Cell Cycle, Proliferation, and Cancer. Springer (2005) 131-183. [Google Scholar]
  23. M. Tanaka-Nozaki, M. Onda, N. Tanaka and S. Kato, Variations in 5-fluorouracil concentrations of colorectal tissues as compared with dihydropyrimidine dehydrogenase dpd) enzyme activities and dpd messenger rna levels. Clin. Cancer Res. 7 (2001) 2783-2787. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.